Dashboard
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of -0.94% and Operating profit at -36.50% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 4.87% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of -0.94% and Operating profit at -36.50% over the last 5 years
3
The company has declared Positive results for the last 4 consecutive quarters
4
With ROE of 0.79%, it has a attractive valuation with a 1.03 Price to Book Value
5
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.39%
0%
-5.39%
6 Months
4.89%
0%
4.89%
1 Year
-4.3%
0%
-4.3%
2 Years
-15.35%
0%
-15.35%
3 Years
-33.6%
0%
-33.6%
4 Years
-48.16%
0%
-48.16%
5 Years
-36.58%
0%
-36.58%
COFCO Biotechnology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-0.94%
EBIT Growth (5y)
-36.50%
EBIT to Interest (avg)
4.55
Debt to EBITDA (avg)
175.16
Net Debt to Equity (avg)
0.29
Sales to Capital Employed (avg)
1.28
Tax Ratio
54.14%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.00%
ROE (avg)
4.87%
Valuation key factors
Factor
Value
P/E Ratio
129
Industry P/E
Price to Book Value
1.03
EV to EBIT
155.61
EV to EBITDA
20.96
EV to Capital Employed
1.02
EV to Sales
0.68
PEG Ratio
0.88
Dividend Yield
NA
ROCE (Latest)
0.66%
ROE (Latest)
0.79%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
4,402.20
4,363.00
0.90%
Operating Profit (PBDIT) excl Other Income
239.50
167.90
42.64%
Interest
27.20
23.20
17.24%
Exceptional Items
13.60
4.50
202.22%
Consolidate Net Profit
68.40
41.80
63.64%
Operating Profit Margin (Excl OI)
23.90%
7.80%
1.61%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 0.90% vs -11.04% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 63.64% vs 74.17% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
19,956.20
20,289.80
-1.64%
Operating Profit (PBDIT) excl Other Income
581.20
53.80
980.30%
Interest
108.30
117.90
-8.14%
Exceptional Items
-3.50
-83.20
95.79%
Consolidate Net Profit
45.70
-616.30
107.42%
Operating Profit Margin (Excl OI)
2.70%
-22.40%
2.51%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -1.64% vs 2.29% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 107.42% vs -158.11% in Dec 2023
About COFCO Biotechnology Co., Ltd. 
COFCO Biotechnology Co., Ltd.
Specialty Chemicals
No Details Available.
Company Coordinates 
No Company Details Available






